Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema
ICD-10 E10.351 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema.
E10.351 refers to a specific complication of Type 1 diabetes mellitus characterized by proliferative diabetic retinopathy (PDR) accompanied by macular edema. PDR is a severe form of diabetic retinopathy where new, abnormal blood vessels grow on the retina, which can lead to vision loss. Macular edema occurs when fluid accumulates in the macula, the central part of the retina responsible for sharp vision. This condition is often a result of prolonged hyperglycemia, leading to damage of the retinal blood vessels. Patients with E10.351 typically have poorly controlled blood glucose levels, often reflected in elevated HbA1c levels, indicating chronic hyperglycemia. Management of this condition involves strict glycemic control, regular eye examinations, and potential interventions such as laser therapy or intravitreal injections to reduce edema and prevent further vision loss. Insulin therapy is crucial for managing Type 1 diabetes, and adjustments may be necessary to achieve optimal blood glucose levels and minimize complications.
Detailed records of blood glucose levels, HbA1c results, and insulin management.
Patients presenting with uncontrolled diabetes and complications such as retinopathy.
Ensure comprehensive documentation of diabetes management plans and patient education.
Detailed eye examination findings, including retinal imaging results.
Patients with visual disturbances due to diabetic retinopathy.
Document the extent of retinal damage and treatment interventions performed.
Used when treating PDR with macular edema.
Document the extent of laser treatment and patient response.
Ophthalmologists should ensure that the diagnosis is clearly linked to the procedure.
HbA1c levels are crucial in managing Type 1 diabetes and indicate the patient's long-term glucose control. Elevated levels can lead to complications like proliferative diabetic retinopathy and macular edema.
Patients should have regular eye examinations, typically annually, and more frequently if they have poor glycemic control or worsening symptoms.
